Viagra, Cialis and Spedra: what you need to know about original brands and their patient information leaflets

Let's be clear. When someone searches for Viagra, Cialis or Spedra, they are often not just looking for a trade name. In reality, they usually want to understand what the brand represents, where to consult its official patient information leaflet, and what information to review before drawing quick conclusions.

Viagra, Cialis and Spedra: what you need to know about original brands and their patient information leaflets

Let's be clear.

When someone searches for Viagra, Cialis or Spedra, they are often not just looking for a trade name. In reality, they usually want to understand what the brand represents, where to consult its official patient information leaflet, and what information to review before drawing quick conclusions. And that's where it's worth pausing for a moment.

Because in topics like erectile dysfunction, oversimplifying doesn't help. It’s not about the name, but about understanding what type of medicine it is, what its official documentation indicates, and why it remains a topic that requires professional assessment.

What we are naming when we talk about Viagra, Cialis and Spedra

Viagra, Cialis and Spedra are reference brands used in the treatment of erectile dysfunction in adult men. In their official data sheets and patient information leaflets, they are presented as prescription-only medicines, and all belong to the same pharmacological group, known as PDE5 inhibitors. The official documentation also identifies their active substance: Viagra contains sildenafil, Cialis contains tadalafil, and Spedra contains avanafil.

It's important to clarify something here. Sharing a therapeutic group does not mean they should be considered interchangeable options for self-medication, nor a decision to be made simply by reading a familiar name. In these types of medicines, the clinical context remains crucial.

Which laboratory is currently listed in the official register for each brand

Many people still associate these brands with their historical laboratories, and this is an understandable query. But speaking with regulatory precision, the most reliable approach is to check which authorisation holder is currently listed in the official European register.

In the current European data sheet, Viagra is listed with Upjohn EESV as the authorisation holder, Cialis with Eli Lilly Nederland B.V., and Spedra with Menarini International Operations Luxembourg S.A. This data is more reliable than relying solely on historical association or what circulates in search engines, because it comes from the current official European register.

In other words: if your goal is to consult the most formal and traceable information about these brands, it makes more sense to rely on EMA and CIMA than on third-party summaries.

What to look for in the official patient information leaflet before drawing conclusions

Reading the patient information leaflet does not serve to decide on a treatment on your own, but it can help you better understand what medicine we are talking about.

If you consult the official patient information leaflet for Viagra, Cialis or Spedra, there are several sections that are usually particularly useful:

  • what the medicine is actually used for
  • what warnings and precautions appear before use
  • with which medicines relevant interactions may occur
  • what adverse effects are most frequently described
  • what instructions for use and storage appear in the official documentation

On CIMA, the official patient information leaflets in Spanish for all three brands are accessible and clearly state from the outset that they are medicines with information intended for the patient, but within a framework of prescription and professional monitoring.

This point is key: the leaflet provides information, but does not replace individual assessment. It serves to better understand, not to turn a health query into an automatic decision.

What limits and precautions necessitate medical assessment

In this group of medicines, the problem is not just "do they work" or "are they well-known". The important point is for whom they may not be suitable, what background factors need to be considered, and what relevant incompatibilities may exist with other treatments.

The official data sheets contain clear warnings. For example, in the case of Viagra and Cialis, restrictions and interactions with nitrates appear, as well as precautions for people with certain cardiovascular problems or eye conditions; Spedra also includes relevant restrictions and interactions within its official documentation.

Therefore, even if the trade name is very well-known, the prudent approach remains the same: do not turn a popular brand into a simplified health decision. In erectile dysfunction, as in other sensitive matters, the responsible thing to do is to understand the context and not trivialise it.

Why these brands continue to generate interest even when there are more options on the market

Although today there are more alternatives and more general knowledge about these treatments, the original brands continue to generate searches for a simple reason: many people identify them as the benchmark. Sometimes they are looking for the name they have known for years. Other times, what they want is to locate the original patient information leaflet, check the official registration, or distinguish the reference brand from other presentations they may find in pharmacies.

From an informational point of view, this search intention makes sense. And precisely for this reason, this page should answer a specific question: what Viagra, Cialis and Spedra represent as original brands and where to consult their official information, without turning the content into a commercial comparison or an implicit recommendation. This approach is what best fits a prudent health blog.

The most important thing to remember

When we talk about Viagra, Cialis and Spedra, we are not just talking about well-known names. We are talking about medicines with official documentation, with a specific regulatory registration and with indications, limitations and interactions that should not be trivialised.

If someone is looking for these brands, the most useful thing is usually this: to understand their place as reference medicines, to consult their official patient information leaflet, and to remember that the trade name does not replace individual medical or pharmaceutical assessment.

In such a sensitive topic as erectile dysfunction, that is probably the most important idea: getting better informed is not the same as better self-medicating.

You may also be interested in reading about erectile dysfunction generics and sildenafil.

Can't find what you're looking for? Ask your pharmacist on WhatsApp +376 622 222